Valued at a market cap of $9.3 billion, Alexandria Real Estate Equities, Inc. (ARE) is a leading life science REIT and specializes in collaborative Megacampus ecosystems in major U.S. life science and technology hubs. As of June 30, 2026, the company had a 36 million RSF of operating properties, and 2.8 million RSF of Class A/A+ properties under construction.
Companies valued less than $10 billion are generally classified as “mid-cap” stocks, and Alexandria Real Estate Equities fits this criterion perfectly. Through its high-quality real estate portfolio and venture capital platform, Alexandria supports innovative life science companies while targeting strong occupancy, rental income, returns, and long-term asset value.
